MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jconrel.2026.115303

Медицинская библиотека · Journal of controlled release : official journal of the Controlled Release Society · 2026

Lung-targeted nanoemulsion repurpose commensal bacteria and tumor cells into in situ vaccines for treating lung cancer.

Xie Mingxin, Xie Zhiqiang, Wang Hairui, Yang Xiaojia, Zhang Yunming, Xiong Kun, Tang Xue, Wang Yuxin, Chen Xueyuan, Zhang Yongshun, You Chengzheng, Luo Huiling, Wei Hongjiao, Ye Lin, Du Guangsheng, Lin Yunzhu, Sun Xun

СтатьяПеревод в очереди

Аннотация

Commensal bacteria represent an influential component of lung cancer by critically affecting tumor metabolism, shaping the immunosuppressive microenvironment, and eroding therapeutic efficacy. Current antibacterial interventions for lung cancer only frame antimicrobials as adjuncts to anti-tumor therapy, failing to leverage the intrinsic adjuvant potential of tumor-resident commensal bacteria, while variable release of bacterial adjuvant components from distinct antibacterial agents and inefficient lung-targeted delivery remain unaddressed. Here, we first identified the antibacterial agent that maximizes release of bacterial adjuvant components, and co-delivered it with a potent immunogenic cell death-inducing anti-tumor drug via an ACE2-binding peptide-modified nanoemulsion to construct an "in situ vaccine" platform while inserting antibacterial and anti-tumor activities, repurposing commensal bacteria from cancer-promoting "accomplices" into immune-stimulatory "in situ adjuvant", thereby eliciting potent immune response. In vivo assays show that the modified nanoemulsion achieved efficient lung accumulation following intravenous injection, suppressed tumor growth and metastasis, eradicated commensal bacteria, reversed the immunosuppressive tumor microenvironment, and activated systemic immune responses.

Для цитирования: Xie Mingxin, Xie Zhiqiang, Wang Hairui, Yang Xiaojia, Zhang Yunming, Xiong Kun, Tang Xue, Wang Yuxin, Chen Xueyuan, Zhang Yongshun, You Chengzheng, Luo Huiling, Wei Hongjiao, Ye Lin, Du Guangsheng, Lin Yunzhu, Sun Xun. Lung-targeted nanoemulsion repurpose commensal bacteria and tumor cells into in situ vaccines for treating lung cancer.. Journal of controlled release : official journal of the Controlled Release Society. 2026. DOI: 10.1016/j.jconrel.2026.115303.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.